Tang Liu Selected Research

Neoplasms (Cancer)

4/2024	Germacrone alleviates breast cancer-associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF-κB signaling pathways.
1/2024	Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
12/2023	An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker.
10/2023	Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
10/2023	FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer.
10/2023	Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers.
8/2023	Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming.
1/2023	Can angiogenesis inhibitor therapy cause changes in imaging features of hepatic hemangioma- Initial study.
1/2023	Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
1/2023	Investigation of the clinicopathological and prognostic role of circMTO1 in multiple cancers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tang Liu Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 09/2012
13	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 12/2012
11	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2016
8	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2018
8	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 10/2014
6	Infections 10/2023 - 12/2012
6	Osteoporosis 12/2022 - 11/2016
3	Bone Resorption 04/2024 - 01/2019
3	Osteolysis 04/2024 - 01/2018
3	Osteoarthritis 04/2023 - 01/2018
3	Chondrosarcoma 02/2023 - 01/2019
3	Necrosis 09/2022 - 12/2012
2	Inflammation (Inflammations) 04/2024 - 10/2022
2	Carcinogenesis 03/2024 - 01/2022
2	Wounds and Injuries (Trauma) 01/2022 - 10/2014
2	Postmenopausal Osteoporosis 12/2020 - 09/2019
2	Ankylosis 09/2019 - 01/2015
1	Hypoxia (Hypoxemia) 08/2023
1	Microsatellite Instability 01/2023
1	Hemangioma (Angioma) 01/2023
1	Compression Fractures (Compression Fracture) 12/2022
1	Hip Fractures (Intertrochanteric Fractures) 09/2022
1	Femoral Neck Fractures 09/2022
1	Hip Dislocation 06/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Giant Cell Tumor of Bone 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
5	Circular RNAIBA 10/2023 - 01/2021
4	RNA (Ribonucleic Acid)IBA 10/2023 - 12/2021
4	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2017
3	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2023
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2023 - 10/2014
3	Cyclin-Dependent Kinase 4IBA 02/2023 - 01/2018
3	Therapeutic UsesIBA 02/2023 - 01/2019
3	palbociclibIBA 02/2023 - 01/2018
2	Actins (F Actin)IBA 04/2024 - 09/2019
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2023
2	Aspartic Acid (Aspartate)FDA Link 12/2023 - 10/2023
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 01/2023
2	Biocompatible Materials (Biomaterials)IBA 04/2023 - 01/2019
2	hesperetinIBA 04/2023 - 01/2019
2	Transfer RNA (tRNA)IBA 01/2023 - 12/2021
2	TitaniumIBA 10/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	CateninsIBA 01/2022 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	Proanthocyanidins (Procyanidins)IBA 11/2019 - 01/2019
2	hypericinIBA 10/2019 - 01/2018
2	Hyaluronic Acid (Hyaluronan)IBA 01/2018 - 01/2018
1	germacroneIBA 04/2024
1	IronIBA 03/2024
1	Non-Receptor Type 3 Protein Tyrosine PhosphataseIBA 01/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2023
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2023
1	Fibronectins (Fibronectin)IBA 10/2023
1	Oxygen (Dioxygen)IBA 08/2023
1	Sulfhydryl Compounds (Thiols)IBA 01/2023
1	batracylinIBA 01/2023
1	nelarabine (506U78)FDA Link 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Axitinib (AG 013736)IBA 01/2023
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	AlloysIBA 10/2022
1	Glucosamine (Dona)IBA 01/2022
1	EnzymesIBA 01/2022
1	CholesterolIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Replication Protein C (Replication Factor C)IBA 01/2022
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022
1	PolymersIBA 01/2022
1	Photosensitizing Agents (Photosensitizers)IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	activin AIBA 12/2021
1	MEF2 Transcription FactorsIBA 12/2021
1	SteroidsIBA 12/2021
1	MyoD1 myogenic differentiation proteinIBA 12/2021

Therapy/Procedure

13	Therapeutics 12/2023 - 02/2013
10	Drug Therapy (Chemotherapy) 03/2024 - 10/2014
10	Immunotherapy 01/2024 - 01/2016
6	Radiotherapy 03/2024 - 01/2018
5	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2019 - 01/2015
4	Prostheses and Implants (Prosthesis) 01/2022 - 12/2012
3	Photochemotherapy (Photodynamic Therapy) 08/2023 - 10/2014
3	External Fixators 05/2019 - 10/2012
3	Limb Salvage 08/2013 - 09/2012
2	Aftercare (After-Treatment) 01/2023 - 12/2020
2	Arthroplasty 09/2022 - 10/2014
2	Osteotomy 06/2022 - 07/2019
2	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2019 - 01/2019
2	Debridement 05/2019 - 08/2013
2	Surgical Amputation (Amputations) 03/2016 - 10/2014
1	Ovariectomy (Oophorectomy) 04/2024
1	Lasers (Laser) 08/2023
1	Vertebroplasty 12/2022
1	Salvage Therapy 01/2022